Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.

Uniphar is expanding its footprint with new facilities in the United States and elsewhere to better support pharma and medtech manufacturers.

The modular sterile filling system reportedly can deliver 500 to 50,000 units per batch specifically tailored for process development.

Researcher suggest findings could help understand what happens in the brain when fear response regulation is impaired.

A new approach that used CRISPR to engineer adipocytes and implant them in mice models of cancer reduced cancer progression.